AI interpretation based on checked source excerpts. Issuer assertions and evidence limitations remain explicit.
Policy quality-scores-2: six equally weighted categories. The overall score requires full coverage. Missing inputs are not zero. Qualitative grades are sourced interpretations, not probabilities. 6/6 · 18/10/2026
Moat63
Equal-weight average of four evidence-backed rubric grades (0–4), scaled to 100.
structural advantage · 3/4 · Proprietary technology, reported productivity-driven adoption and a completed product delivery after almost ten years support a strong technology barrier. Competitive exclusivity is not established.
durability · 2/4 · Long development cycles and continuing service demand support persistence, but the passages do not establish the duration of the competitive lead. Patent expiry, imitation and essential supplier dependence constrain confidence.
customer dependency · 3/4 · Continued advanced Logic and DRAM adoption and service revenue rising from €6.5 billion to €8.2 billion support substantial ongoing dependence indirectly. No retention rate or exclusive service requirement is established.
erosion resilience · 2/4 · Adoption and operating growth show the advantage remains productive. Experienced IP attacks and production constraints, critical optics dependence and possible service substitution create meaningful vulnerabilities without proving realized competitive displacement.
Pricing power63
Equal-weight average of four evidence-backed rubric grades (0–4), scaled to 100.
realized pricing · 2/4 · Negotiated volume discounts and disclosed concessions show that pricing is not unconstrained. Productivity benefits support customer value, but net comparable-product pricing and concession magnitude are absent; neither sustained increases nor broad price deterioration is demonstrated.
retention · 3/4 · Continued product adoption and growing service and field option revenue provide strong indirect evidence of repeat demand and engagement. Installed-base expansion contributes, so these results are not a measured renewal or retention rate.
margin resilience · 3/4 · Reported gross margin increased from 51.3% to 52.8%, while operating margin increased from 31.9% to 34.6% in 2025 despite disclosed supply constraints. This demonstrates recent resilience, without isolating pricing from mix, volume or cost effects or establishing resilience through every cycle.
contractual freedom · 2/4 · Negotiated discounts, free goods or services and purchase credits indicate customer bargaining constraints. Return rights are restricted to failure to meet specifications, providing some contractual protection. General unilateral repricing discretion is not established.
Predictability82
Five consecutive annual periods. Equal weights: nondeclining revenue frequency; revenue-growth volatility (5–40pp); positive FCF frequency; FCF-margin volatility (3–20pp). Stability indicator, not a growth forecast.
- Nondeclining revenue years (%)
- 100.00
- Revenue growth volatility (pp)
- 9.82
- Positive FCF years (%)
- 100.00
- FCF margin volatility (pp)
- 13.15
Financial strength85
Equal-weight grades: debt/FCF (1–8x), net debt/earnings before interest and tax (0–5x), interest service (1–12x), current ratio (0.75–2x). Earnings use reported operating income, or reported pretax profit plus reported interest expense when operating income is unavailable. Interest service uses earnings/interest expense; if unavailable, it uses reported operating cash flow/cash interest paid, without relabeling cash paid as accrued expense. Nonpositive cash flow/earnings score 0 for their service component; reported zero interest with a positive numerator scores 100. Net cash scores 100 for net leverage. Missing disclosures remain unavailable. General nonfinancial-company rubric, not a credit rating; exceptional and nonoperating gains are not normalized out. IFRS finance-cost and cash-flow classifications retain their reported scope.
- debtFcfGrade
- 100.00
- netDebtEbitGrade
- 100.00
- interestCoverageGrade
- 100.00
- currentRatioGrade
- 40.94
- Debt / FCF (x)
- 0.33
- Net debt / operating income (x)
- -0.82
- Interest coverage (x)
- 95.53
- Current ratio (x)
- 1.26
Capital allocation98
Three-year equal-weight indicators: pretax return on average invested capital (0–25%; equity + debt − cash, each year and its prior year), share-count growth (0–5%, lower better), share-based cost/revenue (2–20%, lower better), consolidated FCF/net income (0–1x). Return uses reported operating income or, if unavailable, EBIT calculated from reported pretax profit plus reported interest expense; exceptional/nonoperating gains are not normalized out. Share-based cost uses the reported cash-flow add-back or, if absent, separately reported recognized compensation expense; the latter never becomes an FCF adjustment. Nonpositive net income scores 0 for cash conversion; absent income/FCF stays unavailable. Nonpositive invested capital has no defined return and remains unavailable. Does not establish acquisition quality or buyback timing.
- 3-year pre-tax operating return (%)
- 99.86
- 3-year average dilution (%)
- -0.78
- 3-year average SBC / revenue (%)
- 0.57
- cashConversionGrade
- 93.81
Management69
Equal-weight average of four evidence-backed rubric grades (0–4), scaled to 100.
capital discipline · 3/4 · Reported €11.0 billion free cash flow, €13.3 billion year-end cash and short-term investments, €5.95 billion completed repurchases and actual share cancellations support disciplined funding and shareholder returns. These figures do not establish buyback valuation quality or the returns on every investment.
incentive alignment · 3/4 · Implemented share incentives combine shareholder, financial and nonfinancial measures, with three-year performance and two-year holding periods. The completed 2023–2025 cycle produced disclosed performance-based vesting. This supports alignment without proving exceptional incentive design or executive ownership.
execution · 3/4 · Completed full-specification delivery, continued NXE adoption and realized sales, earnings and cash-flow growth support strong execution from operating outcomes. Attribution of adoption to product benefits remains management's explanation, and first delivery does not establish broad High NA production success.
governance · 2/4 · Actual Supervisory Board incentive assessment, Works Council involvement in a completed appointment and absence of special voting rights support functioning oversight. The preference-share defense has disclosed cancellation safeguards but introduces a control consideration. The passages do not establish exceptional board effectiveness.
Evidence
We have seen strong execution of our technology roadmap across the business, most particularly in EUV with our TWINSCAN NXE:3800E system which continues to be adopted by advanced Logic and DRAM customers due to its higher productivity and cost of technology benefits.
CEO discussion / NXE:3800E customer adoption · Filed 25/02/2026
DRAM has been particularly remarkable this year, as the work we have done to reduce the cost of our EUV per exposure through increased maturity and productivity led to increased adoption.
CEO discussion / EUV cost per exposure and DRAM adoption · Filed 25/02/2026
After almost 10 years of tremendous work from so many people in ASML, we have released our first TWINSCAN EXE:5200B in full specification to our first customer.
CEO discussion / EXE:5200B development and first delivery · Filed 25/02/2026
We rely on intellectual property (IP) rights such as patents, copyrights and trade secrets to protect our proprietary technology.
Risk and security / proprietary technology protection · Filed 25/02/2026
Roger Dassen Executive Vice President and Chief Financial Officer STRATEGIC REPORT CORPORATE GOVERNANCE SUSTAINABILITY FINANCIALS ASML Annual Report 2025 54 At a glance Q&A with the CEO Our business Financial performance Risk and security Financial performance KPIs Sales Profitability Liquidity Total net sales Gross profit % of total net sales Cash and cash equivalents and short-term investments (year end) €32.7bn €17.3bn 52.8% €13.3bn 2024: €28.3bn 2024: €14.5bn 2024: 51.3% 2024: €12.7bn Net system sales Income from operations Net cash provided by operating activities €24.5bn €11.3bn 34.6% €12.7bn 2024: €21.8bn 2024: €9.0bn 2024: 31.9% 2024: €11.2bn Net service and field option sales Net income Free cash flow2 €8.2bn €9.6bn 29.4% €11.0bn 2024: €6.5bn 2024: €7.6bn 2024: 26.8% 2024: €9.1bn Sales of lithography systems (in units)1 Earnings per share (basic) 327 €24.73 2024: 418 2024: €19.25 EUV systems recognized (in units) 48 2024: 44 1.
Financial performance KPIs / 2025 and 2024 operating results · Filed 25/02/2026
4.Patent rights will expire, which may result in key technology becoming widely available, which may harm our competitive position.
IP risk / patent expiry · Filed 25/02/2026
7.Third parties may be able to develop or obtain patents for our own or for similar competing technology.
IP risk / competing technology · Filed 25/02/2026
misappropriation attacks by third parties or our employees,
IP risk / experienced misappropriation attacks · Filed 05/03/2025
Furthermore, if Carl Zeiss SMT were to terminate its supply relationship with us or be unable to maintain production of optics over a prolonged period, we would effectively cease to be able to conduct our business.
Supplier risk / essential optics supply dependence · Filed 25/02/2026
In addition, our installed base revenues are impacted by the number of systems we sell, and other factors; for example, customers may perform more of these services themselves, find other third-party suppliers to provide them, or we may be limited by export control restrictions.
Installed-base revenue risk / self-service, third parties and export controls · Filed 25/02/2026
In our volume purchase agreements we offer customers discounts in the
Revenue recognition / volume agreement discounts · Filed 25/02/2026
normal course of sales negotiations.
Revenue recognition / negotiated discounts · Filed 25/02/2026
As part of these volume purchase agreements, we may also offer free goods or
Revenue recognition / free goods and services · Filed 25/02/2026
services and credits that can be used toward future purchases.
Revenue recognition / future purchase credits · Filed 25/02/2026
Our sales agreements do not include
Revenue recognition / sales agreement return terms · Filed 25/02/2026
a right of return for any reason other than not meeting the agreed-upon specifications.
Revenue recognition / specification-related return exception · Filed 25/02/2026
In 2025, we repurchased 8,323,320 shares (2024: 574,925 shares) for a total consideration of €5,950.0 million (2024: €500.0 million).
Financial statement notes / completed 2025 share repurchases · Filed 25/02/2026
In 2025, we cancelled 5,683,018 shares (2024: 5,754,117 shares).
Financial statement notes / completed share cancellations · Filed 25/02/2026
For the LTI 2023–2025 series, ASML exceeded target on all performance measures – Relative Total Shareholder Return (rTSR), Cash Conversion Rate, Technology Leadership Index and ESG.
Remuneration report / completed 2023–2025 LTI performance · Filed 25/02/2026
The overall LTI result is a vesting of 137.4% of target.
Remuneration report / actual LTI vesting result · Filed 25/02/2026
Shares will become unconditional depending on the achievement of predetermined performance targets during a three-year period, after which a two-year holding period applies.
2025 remuneration policy / performance and holding periods · Filed 25/02/2026
2025 Implementation LTI 2025-2027 target levels CEO Other BoM members LTI 2025-2027 performance measure weighting 25% 40% 35% Relative TSR 25% Financial strategic value drivers 35% Non-financial measures 40% A detailed breakdown of the LTI 2023-2025 vesting levels can be found in section ‘Vesting under the LTI Plan 2023-2025’ of this report.
2025 remuneration implementation / LTI measure weightings · Filed 25/02/2026
Vesting under the LTI Plan 2023–2025 Following the end of the three-year performance period 2023–2025, the Supervisory Board assessed the performance achieved against the LTI targets, in cooperation with the Technology Committee, Audit Committee, ESG Committee and Remuneration Committee.
Remuneration report / Supervisory Board assessment of completed LTI cycle · Filed 25/02/2026
During 2025 we also engaged with the Works Council on specific topics, such as Board of Management and Supervisory Board remuneration and we collaborated with the Works Council on the topic of composition of the Supervisory Board, given the Works Council’s (enhanced) right of recommendation, which led to the appointment of Karien van Gennip as a Supervisory Board member at the 2025 AGM.
Supervisory Board report / Works Council involvement and actual appointment · Filed 25/02/2026
There are no special voting rights on the issued shares in our share capital.
Shareholder rights / voting rights of issued shares · Filed 25/02/2026
STRATEGIC REPORT CORPORATE GOVERNANCE SUSTAINABILITY FINANCIALS ASML Annual Report 2025 316 Financial statements Notes Appendices Definitions Notes to the Consolidated financial statements (continued) If the Foundation does not request that we repurchase or cancel all cumulative preference shares held by the Foundation within 20 months of issuance of these shares, we will be required to convene a General Meeting for the purpose of deciding on a repurchase or cancellation of these shares.
Financial statement notes / preference-share cancellation safeguards · Filed 25/02/2026
Occasionally, we experience supply constraints that affect production.
Supplier risk / experienced production constraints · Filed 25/02/2026